Clinical Trial Update: A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for ALN-APP in cerebral amyloid angiopathy, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Amyloid Angiopathy

Drugs mentioned

• ALN-APP

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Cerebral Amyloid Angiopathy | Phase 2 | Status: RECRUITING